Health Professional Radio - Podcast

Dr. Scott Sigman, Founder and CMO of OrthoLazer and Team Physician at UMASS Lowell, discusses the publication of a second case report demonstrating positive outcomes for a COVID-19 patient treated with adjunct laser therapy. The patient is part of a randomized clinical pilot trial. The treatment is once-daily for four days using an FDA-cleared laser. Photobiomodulation Therapy is known to have anti-inflammatory effects and in this case study it helped treat the patients’ respiratory symptoms.Dr. Sigman is looking to expand this work and raise awareness among other healthcare providers for this novel therapeutic option.